Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$209.36 USD
-1.69 (-0.80%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $209.32 -0.04 (-0.02%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$209.36 USD
-1.69 (-0.80%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $209.32 -0.04 (-0.02%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth B Momentum C VGM
Zacks News
Why Inspire Medical Systems (INSP) Might Surprise This Earnings Season
by Zacks Equity Research
Inspire (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Inspire Medical Systems (INSP) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 20.93% and 8.94%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Inspire Medical Systems (INSP) Q3 Earnings Expected to Decline
by Zacks Equity Research
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 28.89% and 8.96%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Inspire Medical Systems (INSP) Q2 Earnings Expected to Decline
by Zacks Equity Research
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 10.26% and 13.24%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Inspire Medical Systems (INSP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Match Group (MTCH) in Q4 Earnings?
by Zacks Equity Research
Match Group (MTCH) is benefiting from increasing subscriber addition in the form of membership subscriptions. Tinder remains the key catalyst.
U.S. IPO Market Stages Solid Comeback: ETFs to Bet On
by Sweta Killa
The U.S. IPO market recorded the highest activity volume in the first six months of the year since 2014 and the fourth-busiest year-to-date period since 1995.